BCL2 and diffuse large B-cell lymphoma: These findings suggest that advanced DLBCL might have a higher double expression of MYC and BCL2, and this double expression may contribute to the poor prognosis of these patients when compared with localized DLBCLs with lower frequencies of double expression of MYC and BCL2.